Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for rifampin, filing since 1998. Its 2022 FDA inspection closed as VAI.
Registered with DAV (Vietnam) for rifampin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for rifampin. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for rifampin and what filings they hold.
Chat with Fred, your AI analystFixed-dose combinations containing rifampin. Each page leads with the verified API makers of every component.